This NY Times article is one of many talking about how almost no women are choosing to take breast-cancer prevention drug tamoxifen. Doctors and researchers seem concerned about this and are working hard to figure out why, when the reasons seem fairly obvious.
"When the numbers were laid out for them in a way they could clearly understand, they
(
Read more... )